Advancements in Pharmacovigilance: A Comprehensive Research of Emerging Trends and Technologies

Clicks: 3
ID: 309204
2025
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #64 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The field of pharmacovigilance, dedicated to the detection, assessment, understanding, and prevention of adverse effects and other drug-related issues, has experienced profound evolution over the years. This comprehensive research endeavor delves deep into the emerging trends and technologies that are currently reshaping the landscape of pharmacovigilance. This study provides an extensive exploration of the latest advancements in pharmacovigilance methodologies, which include leveraging cutting-edge technologies such as big data analytics, artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) techniques. These transformative tools have revolutionized the process of detecting and assessing adverse drug reactions, enabling rapid and accurate identification of potential risks associated with pharmaceutical products. Furthermore, this research meticulously examines the roles played by regulatory agencies and industry stakeholders in advocating and implementing pharmacovigilance best practices to ensure drug safety. Through in-depth analysis, it sheds light on the deployment of regulatory frameworks such as the Pharmacovigilance Risk Assessment Committee (PRAC) in Europe and the Food and Drug Administration (FDA) in the United States, highlighting their significant impact on drug safety surveillance and the formulation of effective risk management strategies. 
Reference Key
imported_1761926660_6904de046d7c3 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pooja A. Chimane*, Rahul S. Adnaik, Vaishnavi B. Salokhe, Sanyuja R. Khade, Pushpak S. Bari
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2025
DOI
10.62896/ijpdd.2.1.3
URL
https://ijpdd.org/index.php/files/article/view/200
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.